Advanced Non-Small Cell Lung Cancer
Doctors are seeking adults living with non-small cell lung cancer to take part in a new clinical trial.
The purpose of this trial is to determine how well a new study drug works at treating non-small cell lung cancer compared to standard medical care.
There’s no cost to participate, and no health insurance is required to take part or receive study-related care.
Participants may receive a stipend for their time, up to $5,866. Participant caregivers may also receive compensation for their time.
You or a loved one may qualify for the clinical trial if:
At least 18 years old
- Diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC) with HER2-activating mutations
- Additional criteria must also be met to qualify. Our study team is happy to help determine if you or a loved one may be eligible to take part.
